Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma

• Published in: Tomography (Ann Arbor) 2019-03, Vol.5 (1), p.118-126
• Main Authors: Kim, Michelle M, Parmar, Hemant A, Aryal, Madhava P, Mayo, Charles S, Balter, James M, Lawrence, Theodore S, Cao, Yue
• Format: Article
• Language: English
• Subjects: Adult; Aged; Brain Neoplasms - diagnostic imaging; Brain Neoplasms - pathology; Brain Neoplasms - radiotherapy; Contrast Media; Feasibility Studies; Female; Glioblastoma - diagnostic imaging; Glioblastoma - pathology; Glioblastoma - radiotherapy; Humans; Image Interpretation, Computer-Assisted - methods; Magnetic Resonance Imaging, Interventional - methods; Male; Middle Aged; Multimodal Imaging - methods; Multiparametric Magnetic Resonance Imaging - methods; Radiotherapy Planning, Computer-Assisted - methods; Tomography, X-Ray Computed - methods; Workflow
• ISSN: 2379-139X; 2379-1381; 2379-139X
• DOI: 10.18383/j.tom.2018.00035

Quantitative mapping of hyperperfused and hypercellular regions of glioblastoma has been proposed to improve definition of tumor regions at risk for local recurrence following conventional radiation therapy. As the processing of the multiparametric dynamic contrast-enhanced (DCE-) and diffusion-weighted (DW-) magnetic resonance imaging (MRI) data for delineation of these subvolumes requires additional steps that go beyond the standard practices of target definition, we sought to devise a workflow to support the timely planning and treatment of patients. A phase II study implementing a multiparametric imaging biomarker for tumor hyperperfusion and hypercellularity consisting of DCE-MRI and high b-value DW-MRI to guide intensified (75 Gy/30 fractions) radiation therapy (RT) in patients with newly diagnosed glioblastoma was launched. In this report, the workflow and the initial imaging outcomes of the first 12 patients are described. Among all the first 12 patients, treatment was initiated within 6 weeks of surgery and within 2 weeks of simulation. On average, the combined hypercellular volume and high cerebral blood volume/tumor perfusion volume were 1.8 times smaller than the T1 gadolinium abnormality and 10 times smaller than the FLAIR abnormality. Hypercellular volume and high cerebral blood volume/tumor perfusion volume each identified largely distinct regions and showed 57% overlap with the enhancing abnormality, and minimal-to-no extension outside of the FLAIR. These results show the feasibility of implementing a workflow for multiparametric magnetic resonance-guided radiation therapy into clinical trials with a coordinated multidisciplinary team, and the unique and complementary tumor subregions identified by the combination of high b-value DW-MRI and DCE-MRI.